hadlima

Generic: adalimumab-bwwd

Labeler: a-s medication solutions
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name hadlima
Generic Name adalimumab-bwwd
Labeler a-s medication solutions
Dosage Form SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients

adalimumab 40 mg/.8mL

Manufacturer
A-S Medication Solutions

Identifiers & Regulatory

Product NDC 50090-6705
Product ID 50090-6705_f29c7432-aeb1-4eea-b6b1-05572b973220
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761059
Listing Expiration 2026-12-31
Marketing Start 2023-07-01

Pharmacologic Class

Established (EPC)
tumor necrosis factor blocker [epc]
Mechanism of Action
tumor necrosis factor receptor blocking activity [moa]
Chemical Structure
antibodies, monoclonal [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 500906705
Hyphenated Format 50090-6705

Supplemental Identifiers

RxCUI
2640302 2640305
UNII
FYS6T7F842
NUI
N0000175610 N0000175451 M0001357

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name hadlima (source: ndc)
Generic Name adalimumab-bwwd (source: ndc)
Application Number BLA761059 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 40 mg/.8mL
source: ndc
Packaging
  • 1 SYRINGE in 1 CARTON (50090-6705-0) / .8 mL in 1 SYRINGE
source: ndc

Packages (1)

50090-6705-0 1 SYRINGE in 1 CARTON (50090-6705-0) / .8 mL in 1 SYRINGE

Ingredients (1)

adalimumab (40 mg/.8mL)

Linked Drug Pages (1)

HADLIMA ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "f29c7432-aeb1-4eea-b6b1-05572b973220", "openfda": {"nui": ["N0000175610", "N0000175451", "M0001357"], "unii": ["FYS6T7F842"], "rxcui": ["2640302", "2640305"], "spl_set_id": ["7345f276-102e-4175-b7ef-ff1706b05472"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]"], "pharm_class_epc": ["Tumor Necrosis Factor Blocker [EPC]"], "pharm_class_moa": ["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "manufacturer_name": ["A-S Medication Solutions"]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (50090-6705-0)  / .8 mL in 1 SYRINGE", "package_ndc": "50090-6705-0", "marketing_start_date": "20230927"}], "brand_name": "HADLIMA", "product_id": "50090-6705_f29c7432-aeb1-4eea-b6b1-05572b973220", "dosage_form": "SOLUTION", "pharm_class": ["Antibodies", "Monoclonal [CS]", "Tumor Necrosis Factor Blocker [EPC]", "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "product_ndc": "50090-6705", "generic_name": "adalimumab-bwwd", "labeler_name": "A-S Medication Solutions", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "HADLIMA", "active_ingredients": [{"name": "ADALIMUMAB", "strength": "40 mg/.8mL"}], "application_number": "BLA761059", "marketing_category": "BLA", "marketing_start_date": "20230701", "listing_expiration_date": "20261231"}